dazmegrel has been researched along with Diabetic Nephropathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnett, AH; Bennett, J; Britton, JR; Dallinger, K; Leatherdale, BA; Polak, A; Rowe, D; Toop, M; Wakelin, K | 1 |
1 trial(s) available for dazmegrel and Diabetic Nephropathies
Article | Year |
---|---|
Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes.
Topics: Adult; Albuminuria; Clinical Trials as Topic; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Oxidoreductases; Thromboxane B2; Thromboxane-A Synthase | 1984 |